respiratori
syncyti
viru
ci
indepenp
p
p
p
dentli
increas
risk
develop
airflow
declin
year
hct
airflow
declin
immedi
detect
infect
strongest
lowerrespiratorytract
infect
parainfluenza
viru
stabil
month
respiratorytract
viru
infect
year
hct
initi
lung
function
restor
thu
commun
respiratori
virusassoci
airflow
declin
seem
specif
viral
speci
infect
local
perienc
signific
airflow
declin
significantli
increas
mortal
risk
attribut
syndrom
analysi
also
identifi
commun
respiratoryviru
infect
initi
day
hct
signific
risk
factor
develop
sever
airflow
declin
differenti
specif
viral
infect
infect
local
upper
respiratori
tract
urt
lower
respiratori
tract
lrt
given
known
associ
infect
specif
commun
respiratori
virus
form
airway
diseas
investig
contribut
viru
speci
infect
local
made
develop
syndrom
wellcharacter
cohort
patient
receiv
first
allogen
transplant
fred
hutchinson
cancer
research
center
fhcrc
januari
decemb
evalu
pulmonari
function
test
pft
commun
respiratoryviru
infect
note
data
indic
subject
unless
otherwis
indic
fev
forc
expiratori
volum
fvc
forc
volum
capac
gvhd
graftversushost
diseas
hct
hematopoiet
stem
cell
transplant
diseas
hct
lowrisk
diseas
includ
chronic
myeloid
leukemia
chronic
phase
refractori
anemia
aplast
anemia
intermediaterisk
diseas
includ
chronic
myeloid
leukemia
acceler
phase
chronic
phase
blast
phase
acut
leukemia
lymphoma
remiss
refractori
anemia
excess
blast
chronic
lymphocyt
leukemia
paroxysm
nocturn
hemoglobinuria
highrisk
diseas
includ
chronic
myeloid
leukemia
blast
phase
juvenil
chronic
myeloid
leukemia
acut
leukemia
lymphoma
relaps
refractori
anemia
excess
blast
transform
myeloma
b
de
novo
chronic
gvhd
indic
absenc
prior
acut
gvhd
chronic
gvhd
indic
histori
acut
gvhd
either
resolv
onset
chronic
gvhd
prior
hct
year
hct
analysi
restrict
patient
surviv
month
hct
pft
result
avail
baselin
pft
period
clinic
variabl
collect
prospect
part
usual
clinic
care
store
central
databas
diseas
risk
malign
time
hct
classifi
low
intermedi
high
basi
previous
publish
criteria
donor
type
determin
accord
donorrecipi
abo
compat
hlaa
hlab
hladr
statu
acut
graftversushost
diseas
gvhd
grade
use
standard
criteria
categor
yesacut
gvhd
grade
noacut
gvhd
grade
diagnosi
stage
chronic
gvhd
establish
use
previous
publish
criteria
acut
chronic
class
gvhd
integr
categor
noacut
gvhd
chronic
gvhd
acut
gvhd
alon
de
novo
chronic
gvhd
preced
acut
gvhd
chronic
gvhd
preced
acut
gvhd
follow
period
quiescenc
impact
commun
respiratoryviru
urt
infect
lrt
infect
sever
airflow
declin
examin
addit
cytomegaloviru
cmv
pneumonia
pulmonari
aspergillosi
definit
probabl
also
evalu
infect
typic
associ
airflow
declin
fhcrc
institut
review
board
approv
studi
respiratori
specimen
virolog
procedur
throughout
studi
period
hct
recipi
urt
infect
symptom
rhinorrhea
pharyng
coryza
first
day
hct
underw
nasopharyngealthroat
wash
swab
test
patient
radiograph
sign
lrt
infect
underw
bronchoalveolar
lavag
bal
nasopharyngealthroat
wash
swab
sampl
bal
specimen
andor
tissuebiopsi
autopsi
materi
test
commun
respiratori
virus
respiratori
syncyti
viru
rsv
parainfluenza
viru
type
influenzaviru
b
adenoviru
rhinoviru
direct
immunofluoresc
dfa
test
shell
vial
centrifug
cultur
convent
cultur
cultur
inocul
tissu
cultur
contain
rhesu
monkey
kidney
human
foreskin
fibroblast
cell
typespecif
respiratori
dfa
smear
perform
use
commerci
avail
typespecif
antiserum
bartel
vrk
intracel
bal
sampl
also
test
cmv
viral
cultur
shell
vial
centrifug
cultur
dfa
probabl
proven
aspergillu
pulmonari
infect
confirm
posit
cultur
histopatholog
result
bal
lung
biopsi
commun
respiratoryviru
urt
infect
defin
detect
commun
respiratori
viru
nasopharyngealthroat
specimen
cultur
shell
vial
cultur
dfa
conjunct
consist
symptom
absenc
new
infiltr
detect
chest
radiographi
commun
respiratoryviru
lrt
infect
defin
isol
respiratori
viru
cultur
dfa
bal
lung
biopsi
autopsi
specimen
conjunct
symptom
radiograph
new
chang
infiltr
basi
virus
detect
clinic
specimen
categori
commun
respiratoryviru
infect
defin
parainfluenza
infect
rsv
infect
infect
includ
rhinoviru
adenoviru
influenzaviru
b
patient
parainfluenza
infect
regardless
coinfect
consid
parainfluenza
infect
analyz
parainfluenza
categori
criterion
appli
patient
rsv
infect
unless
parainfluenza
viru
also
detect
case
patient
analyz
parainfluenza
categori
pft
airflow
declin
definit
data
analysi
pft
perform
describ
elsewher
forc
expiratori
volum
fev
forc
vital
capac
fvc
express
percentag
predict
normal
valu
calcul
use
publish
equat
children
adult
baselin
hct
day
day
hct
year
year
hct
pft
result
obtain
routin
regardless
presenc
absenc
symptom
signific
airflow
declin
defin
year
declin
percentag
predict
fev
year
year
fev
fvc
ratio
annual
rate
airflow
declin
declin
percentag
predict
fev
year
calcul
use
least
squar
regress
method
annual
rate
declin
percentag
predict
fev
patient
develop
respiratori
infect
commun
respiratori
virus
also
calcul
baselin
day
day
fev
baselin
fev
day
pft
date
baselin
pft
date
day
year
year
fev
day
fev
year
pft
date
day
pft
date
statist
analysi
statist
analys
perform
use
stata
version
statacorp
r
statist
program
avail
http
wwwrprojectorg
twosid
p
valu
consid
statist
signific
univari
analys
conduct
use
x
test
presenc
signific
airflow
declin
year
analyz
multivari
logist
regress
model
outcom
signific
airflow
declin
defin
binari
variabl
independ
variabl
includ
local
infect
speci
commun
respiratori
viru
addit
analysi
perform
determin
risk
sever
airflow
declin
associ
lrt
cmv
infect
pulmonari
aspergillosi
model
adjust
age
hct
baselin
fev
fvc
ratio
gvhd
categori
covari
found
signific
risk
factor
airflow
declin
previou
analysi
kruskallw
test
use
compar
median
rate
declin
percentag
predict
fev
viralinfect
categori
baselin
day
day
year
mortal
cohort
consist
patient
year
followup
pft
result
avail
probabl
overal
surviv
kaplanmei
method
multivari
cox
proportionalhazard
analysi
compar
patient
sever
airflow
declin
patient
without
sever
airflow
declin
describ
initi
studi
firstmyeloabl
allogeneichct
recipi
januari
decemb
elig
studi
case
sever
airflow
declin
identifi
recent
valid
definit
sever
airflow
declin
appli
clinic
characterist
studi
popul
shown
tabl
initi
day
hct
patient
document
viral
infect
commun
respiratori
virus
patient
urt
viral
infect
develop
signific
airflow
declin
year
two
addit
common
lrt
infect
evalu
regard
abil
caus
sever
airflow
declin
longterm
survivor
patient
identifi
cmv
pneumonia
first
day
coinfect
rhinoviru
identifi
pulmonari
aspergillosi
sever
airflow
declin
year
patient
document
viral
infect
lrt
viral
infect
patient
develop
signific
airflow
declin
year
tabl
display
distribut
differ
categori
respiratorytract
viru
infect
accord
presenc
absenc
signific
airflow
declin
year
major
patient
lrt
parainfluenzaviru
infect
lrt
rsv
infect
first
day
develop
signific
airflow
declin
year
none
patient
coinfect
develop
superinfect
bacteri
pathogen
multivari
analysi
includ
covari
previous
determin
signific
risk
factor
signific
airflow
declin
demonstr
presenc
commun
respiratoryviru
lrt
infect
associ
increas
risk
signific
airflow
declin
year
odd
ratio
neither
lrt
p
p
cmv
infect
lrt
aspergillu
infect
found
predict
sever
airflow
declin
data
shown
fev
chang
studi
period
addit
annual
rate
airflow
declin
estim
impact
infect
statu
lung
function
use
chang
percentag
predict
fev
baselin
day
day
viral
infect
diagnos
year
day
median
rate
declin
percentag
predict
fev
patient
lrt
infect
either
parainfluenza
viru
rsv
respect
patient
urt
viral
infect
experienc
rate
declin
percentag
predict
fev
rate
declin
p
p
percentag
predict
fev
patient
lrt
rsv
infect
reach
statist
signific
compar
group
month
infect
day
year
slight
improv
function
median
rate
percentag
predict
fev
increas
depend
type
infect
patient
present
initi
day
figur
median
rate
improv
percentag
predict
fev
statist
differ
differ
categori
infect
p
p
abil
caus
fatal
pneumonia
commun
respiratori
virus
wide
recogn
signific
caus
morbid
mortal
hct
present
studi
suggest
commun
respiratoryviru
infect
might
contribut
increas
overal
mortal
caus
fatal
pneumonia
also
via
longterm
declin
lung
function
inde
initi
studi
reveal
sever
airflow
declin
signific
advers
effect
mortal
adjust
common
caus
death
among
longterm
survivor
hct
found
associ
commun
respiratori
virus
hctrelat
airflow
declin
may
influenc
specif
type
locat
respiratoryviru
infect
multivari
analysi
lrt
viral
infect
found
significantli
increas
risk
develop
airflow
declin
year
hct
risk
particularli
high
patient
develop
lrt
parainfluenzaviru
infect
tabl
lrt
rsv
infect
probabl
also
increas
risk
howev
number
case
small
reach
statist
signific
interestingli
even
urt
parainfluenzaviru
infect
notabl
associ
airflow
declin
suggest
potenti
mechan
previous
report
poor
outcom
associ
urt
parainfluenzaviru
infect
presenc
copathogen
report
signific
risk
factor
death
patient
parainfluenza
pneumonia
present
studi
none
patient
lrt
viral
infect
infect
copathogen
preclud
us
assess
impact
copathogen
might
airflow
declin
associ
respiratorytract
viru
infect
absenc
copathogen
studi
probabl
due
fact
longterm
survivor
respiratorytract
viru
infect
includ
howev
examin
impact
common
pulmonari
pathogen
airflow
declin
expect
neither
lrt
cmv
infect
lrt
aspergillu
infect
increas
risk
sever
airflow
declin
patient
surviv
infect
also
examin
time
develop
airflow
declin
rel
commun
respiratoryviru
infect
signific
declin
percentag
predict
fev
observ
day
hct
day
time
respiratorytract
viru
infect
occur
signific
declin
observ
lrt
infect
compar
urt
infect
consid
caution
limit
inher
perform
multipl
test
although
percentag
predict
fev
patient
experienc
signific
fev
declin
first
day
hct
improv
day
year
none
patient
level
fev
return
baselin
suggest
despit
recoveri
lrt
infect
commun
respiratori
virus
result
perman
loss
lung
function
sever
possibl
explan
phenomenon
prolong
shed
parainfluenza
known
occur
immunosuppress
patient
subclin
shed
respiratori
virus
document
hct
recipi
thu
subclin
persist
viru
respiratori
tract
initi
infect
might
maintain
sustain
airway
inflamm
may
ultim
lead
perman
loss
lung
function
even
appar
clinic
clearanc
infect
commun
respiratori
virus
might
also
activ
inflammatori
process
lrt
patient
surviv
acut
phase
lrt
viru
infect
might
lead
irrevers
damag
tissu
small
airway
independ
viral
replic
present
studi
strength
limit
strength
includ
larg
sampl
size
standard
diagnost
approach
urt
lrt
infect
standard
pft
throughout
studi
period
one
limit
predictor
interest
commun
respiratoryviru
infect
assess
first
day
hct
like
respiratorytract
viru
infect
also
occur
later
patient
discharg
transplant
center
return
less
protect
environ
addit
potenti
contributor
bacteri
coinfect
examin
anoth
possibl
limit
convent
detect
method
use
studi
lack
sensit
may
underestim
true
rate
respiratori
infect
assay
also
unabl
detect
uncultiv
pathogen
human
metapneumoviru
coronavirus
howev
undetect
pathogen
asymptomat
shedder
would
includ
noninfect
group
would
therefor
make
signific
find
even
stronger
possibl
limit
number
case
larg
provid
adequ
power
assess
individu
role
virus
adenoviru
rhinoviru
influenza
viru
play
occurr
signific
airflow
declin
final
patient
surviv
infect
includ
estim
rate
airflow
declin
result
potenti
healthi
survivor
effect
howev
limit
might
actual
result
underestim
impact
respiratori
infect
rate
lung
declin
conclus
present
studi
reveal
parainfluenza
viru
rsv
associ
late
sever
airflow
declin
may
suggest
addit
mechan
respiratori
virus
may
caus
morbid
perhap
even
mortal
hct
data
deserv
investig
focus
understand
mechan
viral
infect
may
lead
develop
sever
airflow
declin
hct
studi
may
ultim
lead
insight
role
viral
infect
play
common
airway
diseas
asthma
